Peter Rudd

2.0k total citations
49 papers, 1.5k citations indexed

About

Peter Rudd is a scholar working on Family Practice, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Peter Rudd has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Family Practice, 13 papers in Cardiology and Cardiovascular Medicine and 12 papers in Geriatrics and Gerontology. Recurrent topics in Peter Rudd's work include Medication Adherence and Compliance (16 papers), Pharmaceutical Practices and Patient Outcomes (12 papers) and Blood Pressure and Hypertension Studies (11 papers). Peter Rudd is often cited by papers focused on Medication Adherence and Compliance (16 papers), Pharmaceutical Practices and Patient Outcomes (12 papers) and Blood Pressure and Hypertension Studies (11 papers). Peter Rudd collaborates with scholars based in United States, United Kingdom and Canada. Peter Rudd's co-authors include Karen Evans, Richard L. Byyny, Mary Loverde, George Greenwald, Robert F. DeBusk, Shaheda Ahmed, Nancy Houston-Miller, J. H. Kaufman, A. Bandura and Wayne D. Mitchell and has published in prestigious journals such as New England Journal of Medicine, JAMA and The American Journal of Medicine.

In The Last Decade

Peter Rudd

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Rudd United States 20 483 452 294 261 211 49 1.5k
Faye Smith United States 16 418 0.9× 397 0.9× 450 1.5× 434 1.7× 202 1.0× 20 1.7k
Marie T. Brown United States 6 272 0.6× 878 1.9× 399 1.4× 331 1.3× 283 1.3× 11 1.7k
Pamela C. Heaton United States 23 286 0.6× 151 0.3× 301 1.0× 213 0.8× 147 0.7× 83 1.4k
Eric J. MacLaughlin United States 18 306 0.6× 256 0.6× 425 1.4× 420 1.6× 123 0.6× 57 1.5k
Kevin C. Farmer United States 16 156 0.3× 590 1.3× 349 1.2× 205 0.8× 197 0.9× 33 1.5k
Linda MacKeigan Canada 20 156 0.3× 327 0.7× 586 2.0× 476 1.8× 287 1.4× 44 1.3k
Tracey‐Lea Laba Australia 20 243 0.5× 411 0.9× 168 0.6× 630 2.4× 364 1.7× 85 1.6k
Rebecca Jeffery Canada 8 341 0.7× 1.1k 2.4× 460 1.6× 447 1.7× 350 1.7× 12 2.1k
Sarah Ross United Kingdom 19 173 0.4× 383 0.8× 507 1.7× 370 1.4× 144 0.7× 46 1.7k
Ruby Grymonpre Canada 15 112 0.2× 317 0.7× 412 1.4× 411 1.6× 221 1.0× 45 1.2k

Countries citing papers authored by Peter Rudd

Since Specialization
Citations

This map shows the geographic impact of Peter Rudd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Rudd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Rudd more than expected).

Fields of papers citing papers by Peter Rudd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Rudd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Rudd. The network helps show where Peter Rudd may publish in the future.

Co-authorship network of co-authors of Peter Rudd

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Rudd. A scholar is included among the top collaborators of Peter Rudd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Rudd. Peter Rudd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sadorge, Christine, Matthew D. Snape, Richard Tomlinson, et al.. (2020). Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series. Vaccine. 38(35). 5718–5725. 1 indexed citations
2.
Migneault, Jeffrey P., Julien Dedier, Julie Wright, et al.. (2012). A Culturally Adapted Telecommunication System to Improve Physical Activity, Diet Quality, and Medication Adherence Among Hypertensive African–Americans: A Randomized Controlled Trial. Annals of Behavioral Medicine. 43(1). 62–73. 87 indexed citations
3.
Pressman, Alice, Andrew L. Avins, John Neuhaus, Lynn Ackerson, & Peter Rudd. (2012). Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST). Contemporary Clinical Trials. 33(3). 492–498. 18 indexed citations
4.
Padula, Amy, Alice Pressman, Eric Vittinghoff, et al.. (2012). Placebo Adherence and Mortality in the Heart and Estrogen/Progestin Replacement Study. The American Journal of Medicine. 125(8). 804–810. 11 indexed citations
5.
Avins, Andrew L., Alice Pressman, Lynn Ackerson, et al.. (2010). Placebo Adherence and Its Association with Morbidity and Mortality in the Studies of Left Ventricular Dysfunction. Journal of General Internal Medicine. 25(12). 1275–1281. 22 indexed citations
6.
Rudd, Peter, et al.. (2009). Acute canine distemper encephalitis is associated with rapid neuronal loss and local immune activation. Journal of General Virology. 91(4). 980–989. 18 indexed citations
7.
Rudd, Peter, Nancy Houston-Miller, J. H. Kaufman, et al.. (2004). . American Journal of Hypertension. 17(10). 921–927. 125 indexed citations
8.
Hopkins, Joseph, et al.. (1998). Drug Therapy: The Impact of Managed Care. Advances in pharmacology. 44. 1–32. 1 indexed citations
9.
Rudd, Peter. (1995). Clinicians and patients with hypertension: Unsettled issues about compliance. American Heart Journal. 130(3). 572–579. 127 indexed citations
10.
Johnson, Brian F. G., et al.. (1995). A Multicenter Comparison of Adverse Reaction Profiles of Isradipine and Enalapril at Equipotent Doses in Patients with Essential Hypertension. The Journal of Clinical Pharmacology. 35(5). 484–492. 6 indexed citations
11.
Rudd, Peter & Leslie Lenert. (1995). Pharmacokinetics as an Aid to Optimising Compliance with Medications. Clinical Pharmacokinetics. 28(1). 1–6. 13 indexed citations
12.
Guerrero, David, et al.. (1993). Antihypertensive Medication-Taking Investigation of a Simple Regimen. American Journal of Hypertension. 6(7 Pt 1). 586–592. 52 indexed citations
13.
Rudd, Peter, et al.. (1992). Issues in Patient Compliance: The Search for Therapeutic Sufficiency. Cardiology. 80(1). 2–10. 25 indexed citations
14.
Eisner, Gilbert M., Brian F. G. Johnson, F. Gilbert McMahon, et al.. (1991). A Multicenter Comparison of the Safety and Efficacy of Isradipine and Enalapril in the Treatment of Hypertension. American Journal of Hypertension. 4(2_Pt_2). 154S–157S. 10 indexed citations
15.
Rudd, Peter, et al.. (1990). Improved compliance measures: Applications in an ambulatory hypertensive drug trial. Clinical Pharmacology & Therapeutics. 48(6). 676–685. 123 indexed citations
16.
Rudd, Peter, et al.. (1989). The natural history of medication compliance in a drug trial: Limitations of pill counts. Clinical Pharmacology & Therapeutics. 46(2). 169–176. 159 indexed citations
17.
Rudd, Peter. (1988). Problems in consultation medicine. Journal of General Internal Medicine. 3(6). 592–595. 3 indexed citations
18.
Rudd, Peter, Richard L. Byyny, Mary Loverde, et al.. (1988). Pill Count Measures of Compliance in a Drug Trial: Variability and Suitability. American Journal of Hypertension. 1(3 Pt 1). 309–312. 78 indexed citations
19.
Rudd, Peter, et al.. (1981). Medication noncompliance. Academic Medicine. 56(1). 59–61. 4 indexed citations
20.
Rudd, Peter, et al.. (1978). Perioperative diabetic consultation. Academic Medicine. 53(7). 590–6. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faye Smith Breakdown of academic impact, for papers by Marie T. Brown Breakdown of academic impact, for papers by Pamela C. Heaton Breakdown of academic impact, for papers by Eric J. MacLaughlin Breakdown of academic impact, for papers by Kevin C. Farmer Breakdown of academic impact, for papers by Linda MacKeigan Breakdown of academic impact, for papers by Tracey‐Lea Laba Breakdown of academic impact, for papers by Rebecca Jeffery Breakdown of academic impact, for papers by Sarah Ross Breakdown of academic impact, for papers by Ruby Grymonpre
Rankless by CCL
2026